TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from China Traditional Chinese Medicine Holdings Co ( (HK:0570) ).
China Traditional Chinese Medicine Holdings Co. Limited has announced the renewal of three key agreements with Sinopharm Group Finance and CNPGC for the period from 2026 to 2028. These agreements include the Financial Services Framework Agreement, the Master Purchase Agreement, and the Master Supply Agreement, which involve financial services, material purchases, and product sales. The transactions are classified as continuing connected transactions under Hong Kong’s listing rules, requiring compliance with specific regulatory requirements. This renewal is expected to strengthen the company’s financial operations and supply chain, enhancing its market position and benefiting stakeholders.
The most recent analyst rating on (HK:0570) stock is a Sell with a HK$1.60 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on the production and distribution of Chinese medicinal products. The company is involved in the healthcare sector, providing various services and products related to traditional Chinese medicine.
Average Trading Volume: 38,918,785
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.63B
See more data about 0570 stock on TipRanks’ Stock Analysis page.